NIH-funded research NIH-funded research

Finding new ways to help repair nerve damage in Multiple Sclerosis

Official title: Accelerating remyelination using lanthionine ketimine derivatives

Funded at Jesse Brown VA Medical Center · NIH-10910001 · Data updated 2026-11-12

This study is looking for new ways to help people with Multiple Sclerosis by testing a special compound that might speed up the healing of nerve coverings, which could improve how their nerves work.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJesse Brown VA Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startOctober 1, 2022
Project endSeptember 30, 2027
Funding year2024
NIH project number5I01RX003955-03
Project IDNIH-10910001 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who have been diagnosed with Multiple Sclerosis.

Less likely to help

Patients with other neurological disorders that do not involve demyelination may not benefit from this research.

What this research studies

This research focuses on discovering new compounds that can speed up the repair of myelin, the protective covering of nerves, in patients with Multiple Sclerosis (MS). Unlike most treatments that aim to reduce immune system damage, this project seeks to enhance the body's ability to regenerate myelin through the use of a semi-synthetic amino acid derivative called Lanthionine Ketimine Ester (LKE). The research involves testing various LKE derivatives in laboratory models to determine their effectiveness in promoting remyelination and improving nerve function. By optimizing dosages and treatment durations, the study aims to provide insights into how these compounds can restore nerve function in MS patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and quality of life for patients with Multiple Sclerosis.

How similar studies have gone: Previous research has shown promise in using similar approaches to enhance remyelination, but this specific method is relatively novel.

Where this research is happening

  • Jesse Brown VA Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Feinstein, Douglas L. — Jesse Brown VA Medical Center
  • Study coordinator: Feinstein, Douglas L.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.